“…The 5‐year OS rate of our patient population was 81%. This value is higher as most survival rates described by other authors, which range between 41% and 70% (Bloebaum, Poort, Böckmann, & Kessler, 2014; Gil et al., 2009; González‐García et al., 2009; Jardim, Francisco, Gondak, Damascena, & Kowalski, 2015; Ong, Murphy, Smith, Kanatas, & Mitchell, 2017; Rogers et al., 2009; Wong et al., 2012; Zanoni et al., 2019). The 5‐year DFS and 5‐year LRC rate were 66% and 75%, respectively.…”